140 related articles for article (PubMed ID: 8951671)
21. Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.
Ahmad Z; Brown CM; Patel AK; Ryan AF; Ongkeko R; Doherty JK
Otol Neurotol; 2010 Apr; 31(3):460-6. PubMed ID: 20195187
[TBL] [Abstract][Full Text] [Related]
22. Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.
Ahmad I; Fernando A; Gurgel R; Jason Clark J; Xu L; Hansen MR
Neurobiol Dis; 2015 Oct; 82():114-122. PubMed ID: 26057084
[TBL] [Abstract][Full Text] [Related]
23. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
[TBL] [Abstract][Full Text] [Related]
24. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas.
Kimura Y; Koga H; Araki N; Mugita N; Fujita N; Takeshima H; Nishi T; Yamashima T; Saido TC; Yamasaki T; Moritake K; Saya H; Nakao M
Nat Med; 1998 Aug; 4(8):915-22. PubMed ID: 9701243
[TBL] [Abstract][Full Text] [Related]
25. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
Lallemand D; Saint-Amaux AL; Giovannini M
J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
27. Loss of merlin-p85 protein complex in NF2-related tumors.
Takeshima H; Nishi T; Yamamoto K; Kino T; Nakamura H; Saya H; Kochi M; Kuratsu JI; Ushio Y
Int J Oncol; 1998 May; 12(5):1073-8. PubMed ID: 9538131
[TBL] [Abstract][Full Text] [Related]
28. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
Petrilli AM; Garcia J; Bott M; Klingeman Plati S; Dinh CT; Bracho OR; Yan D; Zou B; Mittal R; Telischi FF; Liu XZ; Chang LS; Welling DB; Copik AJ; Fernández-Valle C
Oncotarget; 2017 May; 8(19):31666-31681. PubMed ID: 28427224
[TBL] [Abstract][Full Text] [Related]
29. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
30. Generation and Use of Merlin-Deficient Human Schwann Cells for a High-Throughput Chemical Genomics Screening Assay.
Petrilli AM; Fernández-Valle C
Methods Mol Biol; 2018; 1739():161-173. PubMed ID: 29546707
[TBL] [Abstract][Full Text] [Related]
31. Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.
Schulz A; Kyselyova A; Baader SL; Jung MJ; Zoch A; Mautner VF; Hagel C; Morrison H
Brain; 2014 Feb; 137(Pt 2):420-32. PubMed ID: 24309211
[TBL] [Abstract][Full Text] [Related]
32. Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development.
Gutmann DH; Wright DE; Geist RT; Snider WD
Hum Mol Genet; 1995 Mar; 4(3):471-8. PubMed ID: 7795605
[TBL] [Abstract][Full Text] [Related]
33. Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.
Neill GW; Crompton MR
Biochem J; 2001 Sep; 358(Pt 3):727-35. PubMed ID: 11535133
[TBL] [Abstract][Full Text] [Related]
34. Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3.
Blanchard AD; Sinanan A; Parmantier E; Zwart R; Broos L; Meijer D; Meier C; Jessen KR; Mirsky R
J Neurosci Res; 1996 Dec; 46(5):630-40. PubMed ID: 8951674
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.
Gutmann DH; Sherman L; Seftor L; Haipek C; Hoang Lu K; Hendrix M
Hum Mol Genet; 1999 Feb; 8(2):267-75. PubMed ID: 9931334
[TBL] [Abstract][Full Text] [Related]
36. The merlin tumor suppressor localizes preferentially in membrane ruffles.
Gonzalez-Agosti C; Xu L; Pinney D; Beauchamp R; Hobbs W; Gusella J; Ramesh V
Oncogene; 1996 Sep; 13(6):1239-47. PubMed ID: 8808698
[TBL] [Abstract][Full Text] [Related]
37. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.
Lallemand D; Manent J; Couvelard A; Watilliaux A; Siena M; Chareyre F; Lampin A; Niwa-Kawakita M; Kalamarides M; Giovannini M
Oncogene; 2009 Feb; 28(6):854-65. PubMed ID: 19029950
[TBL] [Abstract][Full Text] [Related]
38. Defects in neurofibromatosis 2 protein function can arise at multiple levels.
Gutmann DH; Geist RT; Xu Hm; Kim JS; Saporito-Irwin S
Hum Mol Genet; 1998 Mar; 7(3):335-45. PubMed ID: 9466988
[TBL] [Abstract][Full Text] [Related]
39. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W
Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
